azithromycin monohydrate + azithromycin

**Azithromycin monohydrate + azithromycin** is best interpreted as a specific combination/formulation entry built around **azithromycin**, a macrolide antibacterial agent. Azithromycin binds to the **50S bacterial ribosomal subunit** and inhibits bacterial protein synthesis, providing activity against susceptible respiratory, skin, and sexually transmitted bacterial pathogens. Based on the provided context, this entry most likely reflects an azithromycin oral suspension product in which azithromycin monohydrate is the drug substance form and azithromycin is the active moiety; it is used for mild to moderate bacterial infections including acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin and skin structure infections, acute otitis media, urethritis, cervicitis, and chancroid/genital ulcer disease.

Other names

azithromycin monohydrate + azithromycin